S100A11P9

Across TCGA pan-cancer cohorts, S100A11P9 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated S100A11P9 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher S100A11P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated S100A11P9 expression acts as an unfavorable survival marker, although some lineages such as UCEC and UCS show a favorable association.

MESO, KICH, and LIHC are the cancer types where S100A11P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.153	0.398	.001	93	view →
KICH	DFS	Tertile	All	0.079	0.891	<.001	84	view →
LIHC	OS	Tertile	II,III,IV	0.413	0.741	<.001	72	view →
THCA	DFS	Tertile	II,III,IV	0.442	0.896	<.001	72	view →
ACC	OS	Tertile	All	0.276	0.674	<.001	45	view →
LGG	OS	Tertile	All	0.556	0.899	<.001	42	view →
KIRC	DFS	Tertile	III,IV	0.263	0.504	.016	36	view →
KIRP	OS	Tertile	All	0.714	0.937	.001	36	view →
SKCM	OS	Tertile	IV	0.303	0.778	.004	27	view →
ESCA	DFS	Quartile	All	0.428	0.829	.030	18	view →
OV	OS	Tertile	All	0.627	0.711	.027	12	view →
PRAD	OS	Tertile	All	0.913	0.996	.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

S100A11P9–MESO (DFS)

Open the MESO breakdown →